Advanced Search

2023 Vol. 5, No. 20

Preplanned Studies
Investigation on the Management for Patients with Echinococcosis Treated with Albendazole — Three PLADs, China, 2019
Min Qin, Liying Wang, Ying Wang, Xu Wang, Jiaxi Lei, Xixi Cheng, Yu Feng, Yanyan Hou, Qian Wang, Chuizhao Xue, Laurent Gavotte, Roger Frutos
2023, 5(20): 437-441. doi: 10.46234/ccdcw2023.083
Abstract(4860) HTML (130) PDF 265KB(11)
Abstract:
What is already known about this topic?

In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date.

What is added by this report?

This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties. Out of 634 evaluable patient files, the proportion of patients with a ratio of actual follow-up and reexamination times to theoretical follow-up and reexamination times ≥0.8 were both low (21.92% and 23.19%, respectively).

What are the implications for public health practices?

This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation, follow-up, and reexamination.

Identification of Novel Bartonella washoensis Sequence Type 22 in Marmota himalayana — Jiuquan City, Gansu Province, China, 2021–2022
Ran Duan, Xiaojin Zheng, Qun Duan, Asaiti Bukai, Peng Zhang, Shuai Qin, Xinmin Lu, Dongyue Lyu, Haonan Han, Dan Zhang, Zhaokai He, Junrong Liang, Deming Tang, Jinxiao Xi, Huaiqi Jing, Xin Wang
2023, 5(20): 442-445. doi: 10.46234/ccdcw2023.084
Abstract(4817) HTML (154) PDF 391KB(13)
Abstract:
What is already known about this topic?

The prevalence of rodent-adapted Bartonella species has been increasing significantly. However, the specific Bartonella species carried by Marmota himalayana (M. himalayana), a large rodent species, and the potential risk it poses to human populations remain unknown.

What is added by this report?

Bartonella washoensis (B. washoensis), associated with human endocarditis, was initially identified in M. himalayana, exhibiting a detection rate of approximately one-third and demonstrating a predilection for the heart and lungs. The discovery of the novel Sequence Type 22 has expanded both the isolation source and genetic lineage of B. washoensis.

What are the implications for public health practice?

Individuals residing within the M. himalayana plague focus are at an elevated risk for B. washoensis infection. Consequently, there is a pressing need for public health warnings and efficient clinical case identification in this population.

Associations of Occupational Stress and Coping Styles with Well-Being Among Couriers — Three Cities, Zhejiang Province, China, 2021
Panqi Xue, Yixin Zhang, Fang Wei, Lifang Zhou, Xinglin Fang, Yong Hu, Yu Hong, Shuang Li, Xiaoming Lou, Hua Zou
2023, 5(20): 446-451. doi: 10.46234/ccdcw2023.085
Abstract(4849) HTML (213) PDF 307KB(15)
Abstract:
What is already known about this topic?

Prior research has primarily concentrated on occupational health concerns, including injuries and heatstroke, among couriers. Nevertheless, there has been a scarcity of emphasis on mental health aspects, with existing studies predominantly addressing the risk factors associated with occupational stress.

What is added by this report?

The present study demonstrated a significant association between occupational stress and well-being among couriers, with positive coping strategies acting as a mediating factor. Furthermore, the results indicate that implementing a positive coping style may mitigate the impact of occupational stress on well-being.

What are the implications for public health practice?

Future public policy initiatives should focus on promoting the well-being of couriers by fostering improvements in the workplace environment, reevaluating the organization of work, and delivering support to couriers in managing occupational stress.

Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
Yan Li, Pingshu Zhang, Zhijie An, Ying Ma, Yamin Wang, Liye Wang, Yunqiu Liu, Xiaodong Yuan, Keli Li, Zundong Yin, Huaqing Wang
2023, 5(20): 452-458. doi: 10.46234/ccdcw2023.086
Abstract(5211) HTML (185) PDF 417KB(19)
Abstract:
What is already known on this topic?

Chronic obstructive pulmonary disease (COPD) exacerbations increase household economic burden, but there is limited evidence from prospective cohort studies in China about the impact of vaccination on economic burden.

What is added by this report?

This study demonstrated the economic burden of COPD exacerbations, pneumonia, and hospitalization in COPD patients in China is substantial. Influenza vaccine and 23-valent pneumococcal polysaccharide vaccine (PPSV23), separately or together, were significantly associated with decreased economic burden.

What are the implications for public health practice?

Our study supports evidence on recommendations that COPD patients in China are offered both influenza vaccine and PPSV23.